Analyst Consensus ?
ConsensusHold15 ratings
Bullish426.7%
Neutral960.0%
Bearish213.3%
Sun Life Financial Inc. · SLF · FY2024 Q1 · Calendar Q2 2024
Sun Life: Asia strength offsets U.S. dental and real-estate pressure
The quarter supports a mixed view: Sun Life's Asia franchise, asset growth, and digital initiatives provide growth support, but U.S. dental weakness and market-sensitive businesses make the path uneven.
Reported After market closeNYSEFinancial Services
$43.97B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.11
Consensus $1.20
EPS surprise
-7.5%
Reported versus consensus
Reported revenue
$7.25B
Consensus $887.2M
Revenue surprise
+717.6%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-6.7%
Event window
SPY move
+0.1%
Same window
Abnormal move
-6.8%
Stock minus SPY
Volume
5.6×
Versus trailing sessions
Subsequent drift
-1.3%
Up to 20 sessions
SLFSPY benchmark
Ask FN2 about SLF FY2024 Q1
Transcript, numbers and history already loaded
Why did SLF fall 6.7% after missing EPS estimates in FY2024 Q1?What changed in SLF's guidance and outlook in FY2024 Q1?Give me the bull and bear case for SLF after FY2024 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest analysis shifted the emphasis from broad-based strength to a more mixed picture: Asia and asset growth remained positive, while U.S. dental earnings, mark-to-market effects, and real-estate conditions were more prominent constraints.
Guidance delta
Maintained; management reiterated medium-term objectives and described plans to target higher dental and SLC earnings by 2025.
Key takeaways
- Asia was the main growth engine, led by individual protection sales and new-business CSM growth.
- U.S. dental performance remained weak, with Medicaid-related pressure and repricing central to the recovery plan.
- Asset growth, digital health, and AI initiatives support the longer-term strategy, while rates and real estate remain headwinds.
Management priorities
- Expand Asia distribution and protection growth.
- Improve U.S. dental earnings through repricing and operating recovery.
- Scale digital health and AI-enabled service tools while growing asset-management fees.
Follow SLF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$79.08Previous close
$50.93Low
$76.64Average
$92High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Sep 3, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 10, 2026 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 10, 2023 |
| CFRA | Hold | Hold | Maintain | May 12, 2020 |
| CIBC | Underperform | Neutral | Downgrade | Mar 14, 2019 |
| Scotiabank | Sector Perform | Sector Outperform | Downgrade | Feb 6, 2019 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 5, 2018 |
| BMO Capital | Outperform | Market Perform | Upgrade | Feb 16, 2018 |
| Canaccord Genuity | Hold | Buy | Downgrade | Nov 17, 2016 |
| Jefferies | Hold | Hold | Maintain | Jul 27, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Nov 5, 2015 |
| Cormark Securities | Market Perform | Buy | Downgrade | Dec 19, 2012 |
| Barclays | Underweight | Underweight | Maintain | Nov 9, 2012 |
| Desjardins | Hold | Buy | Downgrade | Oct 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $79.08. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $88 | $79.46 | +11.3% | Sep 3, 2026 |
| Argus Research | Kevin Heal | $81 | $74.52 | +2.4% | Jun 10, 2026 |
| Morgan Stanley | Analyst unavailable | $89 | $60.41 | +12.5% | Oct 7, 2025 |
| Capital One Financial | Tom MacKinnon | $92 | $60.9 | +16.3% | Nov 14, 2024 |
| Stifel Nicolaus | Mike Rizvanovic | $58.89 | $51.95 | -25.5% | Oct 4, 2021 |
| Barclays | John Aiken | $50.93 | $50.38 | -35.6% | Aug 5, 2021 |
Track every rating change on SLF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSun Life Financial Inc. operates as a global financial institution, delivering a wide range of insurance, wealth management, and asset accumulation services to both individual and corporate clients worldwide. Its offerings encompass diverse life insurance products, including term and whole life policies, in addition to personal health, dental, critical illness, long-term care, and disability coverage. The company also engages in reinsurance activities, provides investment advisory and portfolio management services, and administers mutual and segregated funds. Furthermore, it offers trust and banking solutions, along with real estate brokerage, appraisal, and merchant banking services. Its distribution network is extensive, utilizing direct sales representatives, various general agents (both managing and independent), financial intermediaries, broker-dealers, banking institutions, pension and benefits consultants, and other external marketing organizations. Founded in 1871, the firm's headquarters are located in Toronto, Canada.
Historical context
All SLF earningsFinancial Services peers this season
Latest reports in the same sector
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the SLF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
- Polygon adjusted daily market bars · 2026-10-26T07:20:43.194328+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-26T07:20:43.191448+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-26. For educational purposes only; not investment advice.